BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 6083957)

  • 1. [Antithrombin III substitution in patients in shock].
    Vinazzer H; Blauhut B; Bergmann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):806-16. PubMed ID: 6083957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Substitution of antithrombin III in shock patients].
    Blauhut B; Necek S; Vinazzer H; Bergmann H
    Anaesthesist; 1982 Jul; 31(7):349-52. PubMed ID: 7125179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of antithrombin III concentrates].
    Vinazzer H
    Beitr Infusionsther; 1989; 24():151-8. PubMed ID: 2481532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].
    Rodríguez Gómez M; López Fernández MF; Batlle J
    Sangre (Barc); 1993 Dec; 38(6):449-53. PubMed ID: 8171380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Substitution of antithrombin III in shock and consumption coagulopathy].
    Blauhut B; Bergmann H; Vinazzer H
    Wien Klin Wochenschr; 1984 Dec; 96(24):879-81. PubMed ID: 6528617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
    Gómez C; Páramo JA; Rocha E
    Sangre (Barc); 1992 Feb; 37(1):5-10. PubMed ID: 1585238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substitution therapy with an antithrombin III concentrate in shock and DIC.
    Blauhut B; Necek S; Vinazzer H; Bergmann H
    Thromb Res; 1982 Aug; 27(3):271-8. PubMed ID: 7135359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of antithrombin III in endotoxin-induced disseminated intravascular coagulation.
    Hauptman JG; Hassouna HI; Bell TG; Penner JA; Emerson TE
    Circ Shock; 1988 Jun; 25(2):111-22. PubMed ID: 3390893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and stage-related treatment of disseminated intravascular coagulation in meningococcal infections.
    Mertens R; Peschgens T; Granzen B; Heimann G
    Klin Padiatr; 1999; 211(2):65-9. PubMed ID: 10407813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substitution of antithrombin III.
    Breddin HK; Kirchmaier CM
    Wien Klin Wochenschr; 1984 Dec; 96(24):875-9. PubMed ID: 6528616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of disordered antithrombin III function in disseminated intravascular coagulation and deep venous thrombosis for anticoagulant therapy].
    von Blohn G; Reiter B; Hellstern P; Wenzel E; Köhler M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):426-38. PubMed ID: 6083907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrin monomer complexes (SFMC) after substitution of antithrombin III (AT III) in consumption coagulopathy.
    Töpfer G; Ehrhardt W; Dornheim G; Seifert A; Schmidt LH; Senger C; Funke U; Schulze M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):581-5. PubMed ID: 2465977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in antithrombin III activities by administration method in critical patients with disseminated intravascular coagulation: a pharmacokinetic study.
    Aibiki M; Fukuoka N; Nishiyama T; Maekawa S; Shirakawa Y
    Shock; 2007 Aug; 28(2):141-7. PubMed ID: 17515857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of early detection and management of disseminated intravascular coagulation among Alexandria University pediatric intensive care patients.
    El-Nawawy A; Abbassy AA; El-Bordiny M; Essawi S
    J Trop Pediatr; 2004 Dec; 50(6):339-47. PubMed ID: 15537719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen survival and fibrinopeptide A in acute leukemia.
    Castaman G; Galloni E; Dri AV; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):52-6. PubMed ID: 8039760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prophylaxis of consumption coagulopathy in shock. Dependence of the effect of heparin on the activity of antithrombin III (author's transl)].
    Bergmann H; Blauhut B; Necek S; Kramar H; Vinazzer H
    Anaesthesist; 1980 Nov; 29(11):623-6. PubMed ID: 7457802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of hirudin on the consumption of antithrombin III in experimental DIC.
    Hauptmann J; Brüggener E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):83-7. PubMed ID: 2459037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
    Levi M; Toh CH; Thachil J; Watson HG
    Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of disseminated intravascular coagulation with antithrombin III concentrate in children with verified infection].
    Nowak-Göttl U; Groll A; Kreuz WD; Brand M; Breddin HK; von Loewenich V; Kornhuber B
    Klin Padiatr; 1992; 204(3):134-40. PubMed ID: 1614177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-coagulant therapy--antithrombin III].
    Tsuji H
    Rinsho Ketsueki; 1990 Jun; 31(6):750-5. PubMed ID: 2214165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.